Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Middle-aged Men Twice As Likely To Have Diabetes As Women
Men aged 35-54 are almost twice as likely to have diabetes compared to their female counterparts, reveals our new report "Diabetes in the UK 2009" out today.
generic viagra online
Veterans Call For Greater Improvements For Veteran Services
Services for veterans have improved recently, but many veterans say more improvements still need to be made.
News of the day
Lobbyists Battle Over Biologic Drug Protections
"As Congress struggles with a massive health care overhaul, several lobbying powerhouses - including the pharmaceutical industry and the nation"s largest advocacy group for retirees - are locked in a contentious fight over the future of biotechnology drugs," USA Today reports in a front page package. "Both sides have spent heavily to sway lawmakers in the debate over how long to keep the expensive drugs exempt from generic competition." The pharmaceutical industry is fighting for 12 years of exclusivity, while President Barack Obama is "pushing for seven years of exclusivity as he looks to trim costs to help pay for his health care plan. ... The pharmaceutical industry counters that a longer period of exclusivity is needed to recover its investments in "biologic drugs," which are made from living organisms and used to treat cancer, multiple sclerosis and other serious diseases."
Medical Devices

White House Reform Chief Was On Boards Of Health Companies With Suspect Practices

Before taking her job as the White House health reform director, Nancy-Ann DeParle earned more than $6 million serving on the boards of major health care corporations, some of which were accused of fraud, mismanagement and regulatory violations during her tenure, the Investigative Reporting Workshop at American University reports on MSNBC.com. Some critics say the corporate relationships could be a conflict of interest for DeParle. Also, while there"s no evidence DeParle was involved in or aware of allegedly fraudulent activities, in three cases, she served on board committees overseeing the companies" legal and regulatory compliance. For instance, while serving as a director, and compliance committee member at DaVita Inc., a chain of dialysis centers, the company was the "subject of several government probes into its billing and drug-prescribing practices." While DeParle served a similar role at Guidant, it was revealed that the medical equipment supplier knew of cases in which its devices failed, but didn"t disclose the information. "The investigations and lawsuits are at odds with DeParle"s reputation in Washington as a progressive, highly respected health policy analyst," the Investigative Workshop Reports. "During the late 1990s, when she ran Medicare, she pushed hard to raise medical quality standards and to clamp down on fraud and waste in the massive federal health plan for the elderly" (Schulte, 7/2). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009